Will FDA Need A Plan B? Von Eschenbach Hold Exemplifies Agency Politicization, Critics Say
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA risks losing credibility if agency continues to step outside its regulatory limits, panel at FDLI annual conference says.